Literature DB >> 23025880

Cardiac autonomic modulation in polycystic ovary syndrome: does the phenotype matter?

Kristhiane Di Domenico1, Denusa Wiltgen, Fabian J Nickel, Jose Antonio Magalhães, Ruy Silveira Moraes, Poli Mara Spritzer.   

Abstract

OBJECTIVE: To assess whether heart rate variability (HRV) at rest and during sympathetic stimulation is disturbed in patients with different polycystic ovary syndrome (PCOS) phenotypes in comparison to healthy controls.
DESIGN: Cross-sectional study.
SETTING: University hospital. PATIENT(S): Thirty women with classic, anovulatory PCOS, 16 women with ovulatory PCOS, and 23 age-paired women with regular and proven ovulatory cycles. INTERVENTION(S): Anthropometric and hormonal evaluation and analysis of HRV (time and frequency domain HRV indices) at rest and after a mental stress test. MAIN OUTCOME MEASURE(S): Difference between HRV components during rest and stress. RESULT(S): Mean age was 22.80 ± 5.80 years in patients with classic PCOS, 19.81 ± 6.43 years in ovulatory PCOS, and 22.65 ± 5.89 years in controls. During mental stress, patients with classic PCOS showed lower HRV response when compared with the control group, even after adjustment for body mass index (BMI) and age. When patients with classic and ovulatory PCOS were considered together, total T levels were inversely associated with the low frequency component, low frequency/high frequency ratio, and the difference between high frequency response at rest and after the stress test. CONCLUSION(S): Young patients with the classic PCOS phenotype have an impaired autonomic modulation in response to sympathetic stimulation that is typical of considerably older women, or of advanced age.
Copyright © 2013 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23025880     DOI: 10.1016/j.fertnstert.2012.08.049

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  15 in total

1.  Bak Foong pills combined with metformin in the treatment of a polycystic ovarian syndrome rat model.

Authors:  Wenhui Liu; Wenpei Liu; Yuling Fu; Yan Wang; Yuanzhen Zhang
Journal:  Oncol Lett       Date:  2015-07-08       Impact factor: 2.967

Review 2.  Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.

Authors:  Daniel A Dumesic; Sharon E Oberfield; Elisabet Stener-Victorin; John C Marshall; Joop S Laven; Richard S Legro
Journal:  Endocr Rev       Date:  2015-10       Impact factor: 19.871

3.  Autonomic dysfunction in women with polycystic ovary syndrome.

Authors:  Zainab Hasan Hashim; Farqad Bader Hamdan; Anam Rashid Al-Salihi
Journal:  Iran J Reprod Med       Date:  2015-01

4.  Polycystic Ovary Syndrome Presents Higher Sympathetic Cardiac Autonomic Modulation that is not altered by Strength Training.

Authors:  Victor B Ribeiro; Gislaine S Kogure; Rosana M Reis; Ada C Gastaldi; João E DE Araújo; José H Mazon; Audrey Borghi; Hugo C D Souza
Journal:  Int J Exerc Sci       Date:  2016-11-01

5.  Risk factors associated with metabolic syndrome and cardiovascular disease among women with polycystic ovary syndrome in Tabuk, Saudi Arabia.

Authors:  Amani Ali Shaman; Hytham Bahaeldin Mukhtar; Hyder Osman Mirghani
Journal:  Electron Physician       Date:  2017-11-25

6.  Heart rate variability and heart rate turbulence in patients with polycystic ovary syndrome.

Authors:  Gülay Özkeçeci; Bekir Serdar Ünlü; Hüseyin Dursun; Önder Akçi; Gülengül Köken; Ersel Onrat; Alaettin Avşar
Journal:  Anatol J Cardiol       Date:  2015-06-18       Impact factor: 1.596

7.  Genetic variant in vitamin D-binding protein is associated with metabolic syndrome and lower 25-hydroxyvitamin D levels in polycystic ovary syndrome: A cross-sectional study.

Authors:  Betânia Rodrigues Santos; Sheila Bünecker Lecke; Poli Mara Spritzer
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

8.  Apa-I polymorphism in VDR gene is related to metabolic syndrome in polycystic ovary syndrome: a cross-sectional study.

Authors:  Betânia Rodrigues Santos; Sheila Bunecker Lecke; Poli Mara Spritzer
Journal:  Reprod Biol Endocrinol       Date:  2018-04-18       Impact factor: 5.211

9.  Women with Polycystic Ovarian Syndrome Exhibit Reduced Baroreflex Sensitivity That May Be Associated with Increased Body Fat.

Authors:  Stella Vieira Philbois; Ada Clarice Gastaldi; Tábata de Paula Facioli; Ana Carolina Sanches Felix; Rosana Maria Dos Reis; Thauane Hanna Fares; Hugo Celso Dutra de Souza
Journal:  Arq Bras Cardiol       Date:  2019-02-28       Impact factor: 2.000

10.  Polycystic Ovary Syndrome and Cardiovascular Diseases: Still an Open Door.

Authors:  Marcus Vinicius Bolivar Malachias
Journal:  Arq Bras Cardiol       Date:  2019-04       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.